These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12865910)

  • 1. ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases.
    Cappuzzo F; Calandri C; Bartolini S; Crinò L
    Br J Cancer; 2003 Jul; 89(2):246-7. PubMed ID: 12865910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).
    Cappuzzo F; Ardizzoni A; Soto-Parra H; Gridelli C; Maione P; Tiseo M; Calandri C; Bartolini S; Santoro A; Crinò L
    Lung Cancer; 2003 Aug; 41(2):227-31. PubMed ID: 12871787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer.
    Hotta K; Kiura K; Ueoka H; Tabata M; Fujiwara K; Kozuki T; Okada T; Hisamoto A; Tanimoto M
    Lung Cancer; 2004 Nov; 46(2):255-61. PubMed ID: 15474674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain.
    Villano JL; Mauer AM; Vokes EE
    Ann Oncol; 2003 Apr; 14(4):656-8. PubMed ID: 12649117
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of gefitinib on brain metastases from non-small cell lung cancer.
    Nishi N; Kawai S; Yonezawa T; Fujimoto K; Masui K
    Neurol Med Chir (Tokyo); 2006 Oct; 46(10):504-7. PubMed ID: 17062991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain metastases in metastatic non-small cell lung cancer responding to single-agent gefitinib: a case report.
    Stemmler HJ; Weigert O; Krych M; Schoenberg SO; Ostermann H; Hiddemann W
    Anticancer Drugs; 2005 Aug; 16(7):747-9. PubMed ID: 16027524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gefitinib and erlotinib for non-small cell lung cancer patients who fail to respond to radiotherapy for brain metastases.
    Song Z; Zhang Y
    J Clin Neurosci; 2014 Apr; 21(4):591-5. PubMed ID: 24256883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
    Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
    Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.
    Yang RF; Yu B; Zhang RQ; Wang XH; Li C; Wang P; Zhang Y; Han B; Gao XX; Zhang L; Jiang ZM
    Braz J Med Biol Res; 2017 Nov; 51(1):e6073. PubMed ID: 29185589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal cystic change of brain metastasis after response to gefitinib in non-small-cell lung cancer.
    Zee YK; Chin TM; Wong AS
    J Clin Oncol; 2009 Oct; 27(30):e145-6. PubMed ID: 19667265
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole-brain radiation fails to boost intracerebral gefitinib concentration in patients with brain metastatic non-small cell lung cancer: a self-controlled, pilot study.
    Fang L; Sun X; Song Y; Zhang Y; Li F; Xu Y; Ma S; Lin N
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):873-7. PubMed ID: 26310285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis.
    Chen Y; Wang M; Zhong W; Zhao J
    Lung Cancer; 2013 Nov; 82(2):313-8. PubMed ID: 24011632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study.
    Zeng YD; Zhang L; Liao H; Liang Y; Xu F; Liu JL; Dinglin XX; Chen LK
    Asian Pac J Cancer Prev; 2012; 13(3):909-14. PubMed ID: 22631670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity.
    Chiu CH; Tsai CM; Chen YM; Chiang SC; Liou JL; Perng RP
    Lung Cancer; 2005 Jan; 47(1):129-38. PubMed ID: 15603863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of whole-brain radiotherapy on remission of brain metastases.
    Nieder C
    J Clin Oncol; 2006 Aug; 24(24):4037; author reply 4037-8. PubMed ID: 16921062
    [No Abstract]   [Full Text] [Related]  

  • 17. Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.
    Namba Y; Kijima T; Yokota S; Niinaka M; Kawamura S; Iwasaki T; Takeda Y; Kimura H; Okada T; Yamaguchi T; Nakagawa M; Okumura Y; Maeda H; Ito M
    Clin Lung Cancer; 2004 Sep; 6(2):123-8. PubMed ID: 15476598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity.
    Ballard P; Yates JW; Yang Z; Kim DW; Yang JC; Cantarini M; Pickup K; Jordan A; Hickey M; Grist M; Box M; Johnström P; Varnäs K; Malmquist J; Thress KS; Jänne PA; Cross D
    Clin Cancer Res; 2016 Oct; 22(20):5130-5140. PubMed ID: 27435396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain metastasis responding to gefitinib alone.
    Poon AN; Ho SS; Yeo W; Mok TS
    Oncology; 2004; 67(2):174-8. PubMed ID: 15539923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gefitinib ('Iressa', ZD1839) is active against brain metastases in a 77 year old patient.
    Roggero E; Busi G; Palumbo A; Pedrazzini A
    J Neurooncol; 2005 Feb; 71(3):277-80. PubMed ID: 15735917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.